News & Events

Learn about what's new with CMC Biologics

Bob Broeze

SVP Business Development

Recent Posts by Bob Broeze:

Biotech Showcase, January 9-13

Events

biotech-showcase-2017_b.jpgJanuary 9 – 13, 2017 | Biotech Showcase, San Francisco, CA, U.S.A. 

CMC Biologics is in San Francisco, for both the Biotech Showcase and the JP Morgan 34th Annual Healthcare Conference. Our PROVEO alliance is a Biotech Showcase sponsor. Join us to learn how PROVEO provides the most complete, efficient and fully-customized ADC solution available to the market, today.

Contact us to set up a meeting with our team, to learn more.

European Antibody Congress, November 14 - 16, Booth #9

Events

November 14 - 16, 2016 | European Antibody Congress, Basel, Switzerland

european-antibody-cropped.jpgVisit CMC Biologics at booth #9, during the European Antibody Congress in Basel, Switzerland. Join us at the Congress Center Basel, and learn why CMC Biologics is leading the industry in contract development and manufacturing of monoclonal antibodies and other therapeutic proteins.

BIO Europe, November 7 - 9, Booth #43

Events

November 7 – 9, 2016 | BIO-Europe, Cologne, Germany

Visit CMC Biologics at booth #43, during BIO-Europe in Cologne, Germany.

bio-europe-2.pngJoin us and learn why CMC Biologics is leading the industry in contract development and manufacturing of monoclonal antibodies and other therapeutic proteins.

CMC Biologics Participates in Denmark State Visit to Korea

News

CMC Biologics Copenhagen Facility site head Patricio Massera, was honored to participate in the recent Danish State Visit to Korea

CMC Biologics was chosen for inclusion in the state visit, along with representatives from other select Danish companies in the Health Industry, for participation in a Denmark- Korea Roundtable Meeting on Health.

BioProduction , October 19 - 20, Booth #29

Events

October 19 – 20, 2016 | BioProduction Congress, Dublin, IrelandBioProduction-Congress-logo-sky-blue-01-1f3949df179376b9267f76b8b38766d5.png

CMC Biologics and IDT Biologika Announce the Addition of Cerbios-Pharma and Oncotec Pharma to their Strategic Collaboration

News

Cerbios-Pharma will Provide Highly Cytotoxic Drug Payloads and Conjugation Services for Manufacture of ADC Drug Substance

Oncotec Pharma will Provide Sterile Filling and Lyophilization of Cytotoxic Active Ingredients for ADCs

Biotech Week Boston, 2016

Events

October 4 – 7, 2016 | Biotech Week Boston - BioProcess International Conference & Exhibition

BioProcess International, October 4 - 7, Booth #1035

Events

October 4 – 7, 2016 | BioProcess International Conference & Exhibition, Boston, Mass.

BPI-header-logo.pngVisit CMC Biologics at booth #1035, during the BioProcess International Conference & Exhibition (BPI), held at the Boston Convention and Exhibition Center.

Join us and learn why CMC Biologics is leading the industry in contract development and manufacturing of monoclonal antibodies and other therapeutic proteins.

Our own Michelle Najera, PhD., will be speaking during the pre-conference symposia. Make time to attend her insightful presentation:

  • Why CMO means "Continuous Manufacturing Organization"

  • Date/Time: Tuesday, October 4th, 4PM

  • Track: Symposium 2: Continuous Processing

CPhI Worldwide, October 4 - 6, Barcelona, Spain

Events

October 4 – 6, 2016 CPhI Worldwide, Barcelona, Spain

CPhI_banner_Static_300x600_2016_Barcelona.pngCPhI Worldwide , together with co-located events ICSE, InnoPack, P-MEC and FDF, hosts more than 36,000 visiting pharma professionals over three days. 2,500+ exhibitors from 150+ countries gather at the event to network and take advantage of more than 100 industry seminars covering every sector of the pharmaceutical market.

This year’s event is located at the Fira de Barcelona Gran Via, in Barcelon, Spain. If you’re attending, make time to see  CMC Biologics' CEO, Gustavo Mahler, PhD., as he participates in a truly informative panel:

CMC Biologics Cleared for Commercial Manufacture of CSL Behring's FDA-Approved AFSTYLA®

News

Bulk Drug Intermediate Produced in CMC Biologics’ Copenhagen, Denmark Facility

COPENHAGEN, Denmark and BOTHELL, Wash. – June 16, 2016 CMC Biologics, a global leader in clinical and commercial manufacturing of monoclonal antibodies, coagulation factors and other therapeutic proteins, today announced that it will supply bulk drug intermediate for CSL Behring’s recently FDA-approved product, AFSTYLA® [Antihemophilic Factor (Recombinant), Single Chain], its novel long-lasting recombinant factor VIII single-chain therapy for adults and children with hemophilia A, to reduce the frequency of bleeding episodes; on-demand treatment and control of bleeding episodes; and the perioperative management of bleeding.